MDCO

Medicines Co

MDCO

Delisted

MDCO was delisted on the 3rd of January, 2020.

283 hedge funds and large institutions have $8.36B invested in Medicines Co in 2019 Q4 according to their latest regulatory filings, with 106 funds opening new positions, 71 increasing their positions, 88 reducing their positions, and 66 closing their positions.

2020 Q3 2020 Q2 2020 Q1 2019 Q4 2019 Q3 2019 Q2 2019 Q1 2018 Q4 2018 Q3 2018 Q2 2018 Q1 2017 Q4 2017 Q3 2017 Q2 2017 Q1 2016 Q4 2016 Q3 2016 Q2 2016 Q1 2015 Q4 2015 Q3 2015 Q2 2015 Q1 2014 Q4 2014 Q3 2014 Q2 2014 Q1 2013 Q4 2013 Q3 2013 Q2

Holders

283

Holders Change

+33

Holders Change %

+13.2%

% of All Funds

5.59%

Holding in Top 10

Holding in Top 10 Change

+24

Holding in Top 10 Change %

+171.43%

% of All Funds

0.75%

New

106

Increased

Reduced

Closed

Calls

$1.12B

Puts

$951M

Net Calls

+$173M

Net Calls Change

+$270M

Top Buyers

1	HI 1 HBK Investments Dallas, Texas	$330M
2	FCM 2 Farallon Capital Management San Francisco, California	$282M
3	CS 3 Credit Suisse Zurich, Switzerland	$245M
4	4 Citigroup New York	$216M
5	MF 5 Magnetar Financial Evanston, Illinois	$161M

Top Sellers

1	1 Wellington Management Group Boston, Massachusetts	$36.6M
2	2 Fidelity Investments Boston, Massachusetts	$51K
3	3 Westfield Capital Management Boston, Massachusetts	$116M
4	SPC 4 Slate Path Capital New York	$69.5M
5	MC 5 Maverick Capital Dallas, Texas	$185M

#	Name	Market Value	Shares	Shares Change	Shares Change %
1	1 BlackRock New York	$1.03B	12,101,435	+224,229	+2%
2	2 Vanguard Group Malvern, Pennsylvania	$648M	7,632,116	+157,418	+2%
3	SCM 3 Sarissa Capital Management Greenwich, Connecticut	$357M	4,202,000	–	–
4	HI 4 HBK Investments Dallas, Texas	$330M	3,880,000	+3,880,000	New
5	FCM 5 Farallon Capital Management San Francisco, California	$282M	3,315,000	+3,315,000	New
6	6 State Street Boston, Massachusetts	$262M	3,085,089	-423,176	-12%
7	CS 7 Credit Suisse Zurich, Switzerland	$245M	2,884,978	+2,821,428	+4,440%
8	8 Citigroup New York	$216M	2,541,983	+2,275,369	+853%
9	MC 9 Maverick Capital Dallas, Texas	$185M	2,176,487	-1,707,552	-44%
10	MF 10 Magnetar Financial Evanston, Illinois	$161M	1,892,832	+1,892,832	New
11	AAM 11 Alpine Associates Management Palm Beach, Florida	$135M	1,590,435	+1,590,435	New
12	AA 12 AQR Arbitrage Greenwich, Connecticut	$130M	1,528,417	+1,528,417	New
13	IAM 13 Iridian Asset Management Westport, Connecticut	$123M	1,448,662	-1,552,700	-52%
14	14 Westfield Capital Management Boston, Massachusetts	$116M	1,368,720	-5,099,682	-79%
15	15 Wells Fargo San Francisco, California	$111M	1,301,226	+704,224	+118%
16	16 Millennium Management New York	$110M	1,291,001	+951,684	+280%
17	17 UBS Group Zurich, Switzerland	$108M	1,277,342	+754,143	+144%
18	18 Bank of America Charlotte, North Carolina	$104M	1,220,832	+307,362	+34%
19	DLPIC 19 Davide Leone & Partners Investment Company London, United Kingdom	$97.4M	1,146,192	+1,146,192	New
20	20 Susquehanna International Group Bala Cynwyd, Pennsylvania	$92M	1,082,774	+1,041,021	+2,493%
21	21 Morgan Stanley New York	$89.8M	1,057,383	+756,359	+251%
22	22 Geode Capital Management Boston, Massachusetts	$89.3M	1,050,757	+46,525	+5%
23	23 Goldman Sachs New York	$83.8M	986,518	+355,944	+56%
24	BC 24 Boxer Capital San Diego, California	$82.1M	967,000	+217,000	+29%
25	UOC 25 UBS O'Connor Chicago, Illinois	$82.1M	966,509	+966,509	New

Medicines Co MDCO

Top Buyers

Top Sellers

Medicines Co

MDCO